The AMD Center

Filter Your Results

 

News

 

Ultra-Widefield Imaging for Age-Related Macular Degeneration

Nathan Arboleda, BS; John B. Miller, MD; Ines Laíns, MD, PhD; Deeba Husain, MD; and Patrick Oellers, MD

Silicone Oil Droplets After Bevacizumab Intravitreal Injecti…

Intravitreal injection of VEGF antagonists is the accepted gold standard for the management of neovascular (exudativ…

Eric K. Chin, MD; and David R.P. Almeida, MD, MBA, PhD

Phase 3 in Retina: The Trials to Know

Clinical trials now under way or recently completed have the potential to make new therapeutic options available soo…

Michael Ammar, MD; and Jason Hsu, MD

Reframing the Retina Pipeline

It is tempting to observe the retina therapeutics and pharmacology pipeline the way we watch a horse race -- which c…

Pravin U. Dugel, MD

The Neovascular AMD Pipeline

The names of new drugs, studies, and companies fly around at retina meetings. It can be difficult to keep the names …

Priyatham (Prithu) S. Mettu, MD

Looking to the Future of Gene Therapy in Ophthalmology

The inaugural Future is Now: Leaders in Ocular Gene Therapy Meeting, focusing on gene therapy in ophthalmology, took…

Kourous A. Rezaei, MD

The Future of Home-Based OCT for Retina Patients

Telemedicine is on the rise. Today, the landscape of telemedicine ranges from remote patient consultations to handhe…

John B. Miller, MD; and Rebecca Zeng, BA; With Sidebar Commentary by Judy E. Kim, MD

Gene Therapy Approach Demonstrated Safety With Durable Effec…

There is no doubt that anti-VEGF therapy has revolutionized care for individuals w

Jeffrey S. Heier, MD; Allen C. Ho, MD; and Robert L. Avery, MD

 

This Month's Supplements

 
 

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Scott Krzywonos
Editor-in-Chief
484-581-1880
skrzywonos@bmctoday.com

Janet Burk
Publisher
214-394-3551
jburk@bmctoday.com

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.